{"id":"W2912026765","doi":"10.1016/j.msard.2019.01.044","title":"Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"Schweizerische Multiple Sklerose Gesellschaft; European Commission; Universitätsspital Basel; Bayer HealthCare; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Novartis Foundation; F. Hoffmann-La Roche","keywords":"Medicine; Ocrelizumab; Oratorio; Multiple sclerosis; Opera; Internal medicine; Literature; Psychiatry; Musical; Art","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008733651,0.0006203403,0.001446265,0.0002121914,0.0009667028,0.0001640495,0.000192858,0.0002648857,0.00002671047],"category_scores_gemma":[0.002909814,0.0003560045,0.000114239,0.0005821034,0.001604808,0.0005408705,0.000766361,0.0007491551,0.000004505277],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001383471,"about_ca_system_score_gemma":0.00008484554,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008448737,"about_ca_topic_score_gemma":0.0002102567,"domain_scores_codex":[0.9957859,0.0004517104,0.001032659,0.001242643,0.0007896337,0.0006974453],"domain_scores_gemma":[0.9964347,0.001977239,0.0003538275,0.0006083291,0.000348772,0.0002771096],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1492018,0.001768986,0.7132612,0.0002043697,0.001345878,0.000009248649,0.06500603,0.0001045593,0.008751341,0.000008824056,0.0003515187,0.05998621],"study_design_scores_gemma":[0.415179,0.00102871,0.5661527,0.003790585,0.0001610366,0.000001776713,0.008621794,0.004167132,0.0001809646,0.00001268618,0.0002162362,0.000487347],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9705535,0.02233043,0.000003314379,0.001510614,0.0002082697,0.005060262,0.0001193773,0.00008645965,0.0001277685],"genre_scores_gemma":[0.9599916,0.03845803,0.0005988757,0.0002335873,0.00002958627,0.0003979866,0.0001556276,0.0000656798,0.00006902521],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2659773,"threshold_uncertainty_score":0.9998892,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0340385116582444,"score_gpt":0.2778177616240176,"score_spread":0.2437792499657732,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}